Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of remimazolam for awake fiberoptic intubation sedation
ChiCTR2300075614Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam in difficult airway (3 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: Time to achieve sedation, Airway obstruction score and 3 more. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
difficult airway
Beyond the preview
Go deeper on ChiCTR2300075614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075614.